MXCT — MaxCyte Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for MaxCyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	34.8	255	227	168	154
Net Total Accounts Receivable
Net Total Receivables	5.17	6.88	13.6	5.78	4.68
Total Inventory
Prepaid Expenses
Total Current Assets	45.3	270	252	190	172
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.49	13.4	33.6	34.8	30.5
Long Term Investments
Other Long Term Assets
Total Assets	51.8	284	287	268	239
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.6	15.6	15.4	17.9	15.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	18.6	21.2	32.7	36.1	33.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	33.2	263	254	232	206
Total Liabilities & Shareholders' Equity	51.8	284	287	268	239
Total Common Shares Outstanding